ARTICLE | Distillery Therapeutics
Cancer
October 27, 2016 7:00 AM UTC
Patient sample, cell culture and mouse studies suggest inhibiting KDM6B could help treat hepatocellular carcinoma (HCC). In patients, high tumor KDM6B expression correlated with poor survival. In huma...
BCIQ Target Profiles